These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 27189479

  • 1. In vitro and in vivo antineoplastic and immunological effects of pterocarpanquinone LQB-118.
    Salustiano EJ, Dumas ML, Silva-Santos GG, Netto CD, Costa PR, Rumjanek VM.
    Invest New Drugs; 2016 Oct; 34(5):541-51. PubMed ID: 27189479
    [Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory properties of pterocarpanquinone LQB-118 in mice.
    Riça IG, Netto CD, Rennó MN, Abreu PA, Costa PRR, da Silva AJM, Cavalcante MCM.
    Bioorg Med Chem; 2016 Sep 15; 24(18):4415-4423. PubMed ID: 27492193
    [Abstract] [Full Text] [Related]

  • 3. Insights into the Biological Evaluation of Pterocarpanquinones and Carbapterocarpans with Anti-tumor Activity against MDR Leukemias.
    Rumjanek VM, Maia RC, Salustiano EJ, Costa PRR.
    Anticancer Agents Med Chem; 2019 Sep 15; 19(1):29-37. PubMed ID: 29692266
    [Abstract] [Full Text] [Related]

  • 4. The orally active pterocarpanquinone LQB-118 exhibits cytotoxicity in prostate cancer cell and tumor models through cellular redox stress.
    Martino T, Kudrolli TA, Kumar B, Salviano I, Mencalha A, Coelho MGP, Justo G, Costa PRR, Sabino KCC, Lupold SE.
    Prostate; 2018 Feb 15; 78(2):140-151. PubMed ID: 29105806
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. LQB-118, a pterocarpanquinone structurally related to lapachol [2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone]: a novel class of agent with high apoptotic effect in chronic myeloid leukemia cells.
    Maia RC, Vasconcelos FC, de Sá Bacelar T, Salustiano EJ, da Silva LF, Pereira DL, Moellman-Coelho A, Netto CD, da Silva AJ, Rumjanek VM, Costa PR.
    Invest New Drugs; 2011 Dec 15; 29(6):1143-55. PubMed ID: 20499132
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. N-propionyl-4-S-cysteaminylphenol induces apoptosis in B16F1 cells and mediates tumor-specific T-cell immune responses in a mouse melanoma model.
    Ishii-Osai Y, Yamashita T, Tamura Y, Sato N, Ito A, Honda H, Wakamatsu K, Ito S, Nakayama E, Okura M, Jimbow K.
    J Dermatol Sci; 2012 Jul 15; 67(1):51-60. PubMed ID: 22622238
    [Abstract] [Full Text] [Related]

  • 9. The pterocarpanquinone LQB 118 induces apoptosis in tumor cells through the intrinsic pathway and the endoplasmic reticulum stress pathway.
    de Sá Bacelar T, da Silva AJ, Costa PR, Rumjanek VM.
    Anticancer Drugs; 2013 Jan 15; 24(1):73-83. PubMed ID: 22960938
    [Abstract] [Full Text] [Related]

  • 10. The anti-tumor effect of bee honey in Ehrlich ascite tumor model of mice is coincided with stimulation of the immune cells.
    Attia WY, Gabry MS, El-Shaikh KA, Othman GA.
    Egypt J Immunol; 2008 Jan 15; 15(2):169-83. PubMed ID: 20306700
    [Abstract] [Full Text] [Related]

  • 11. Biochemical analysis and antitumour effect of Abrus precatorius agglutinin derived peptides in Ehrlich's ascites and B16 melanoma mice tumour model.
    Behera B, Devi KS, Mishra D, Maiti S, Maiti TK.
    Environ Toxicol Pharmacol; 2014 Jul 15; 38(1):288-96. PubMed ID: 25000506
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma.
    Baral R, Chattopadhyay U.
    Int Immunopharmacol; 2004 Mar 15; 4(3):355-66. PubMed ID: 15037213
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combination of HDAC inhibitor MS-275 and IL-2 increased anti-tumor effect in a melanoma model via activated cytotoxic T cells.
    Kato Y, Yoshino I, Egusa C, Maeda T, Pili R, Tsuboi R.
    J Dermatol Sci; 2014 Aug 15; 75(2):140-7. PubMed ID: 24866536
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combination therapy with TiO2 nanoparticles and cisplatin enhances chemotherapy response in murine melanoma models.
    Adibzadeh R, Golhin MS, Sari S, Mohammadpour H, Kheirbakhsh R, Muhammadnejad A, Amanpour S, Moosavi MA, Rahmati M.
    Clin Transl Oncol; 2021 Apr 15; 23(4):738-749. PubMed ID: 32734535
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.